Hebert Biotech Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2019.
2019 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Hebert Biotech Private Limited

Hebert Biotech Private Limited, a active private limited company, was established on 20 September 2019 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U52601DL2019PTC355342. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.20 M.

Formerly known as Hebert Bio Private Limited. Its leadership includes Siddhant Varshney (Director), Chetan Kumar Gupta (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at C-24, S/F, Dsidc Industrial Complex, Patparganj, New Delhi, Delhi, 110092.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U52601DL2019PTC355342

  • Registration Number

    355342

  • Incorporation Date

    20 September 2019

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.20 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.20 M
  • Company Age 6 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Profit Growth **** 863.94%
  • Ebitda **** 1280.83%
  • Net Worth 53.03%
  • Total Assets **** 1170.47%
Company report

Hebert Biotech Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Hebert Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Hebert Biotech Private Limited?
Current Directors
Name Designation Appointment Date Status
Siddhant Varshney Director 20 Sep 2019 Current
Chetan Kumar Gupta Director 20 Sep 2019 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Hebert Biotech.

Hebert Biotech Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 863.94% increase in profit. The company's net worth Soared by an impressive increase of 53.03%.

Hebert Biotech revenue growth over time
Hebert Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 1170.47%
*******
*******
*******
*******
Profit or Loss
*******
 863.94%
*******
*******
*******
*******
Net Worth
*******
 53.03%
*******
*******
*******
*******
EBITDA
*******
 1280.83%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Hebert Biotech?

In 2021, Hebert Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Hebert Biotech?

Unlock and access historical data on people associated with Hebert Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Hebert Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hebert Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Hebert Biotech
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Hebert Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Hebert Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Director Appointment

    Siddhant Varshney was appointed as a Director was appointed as a Director on 20 Sep 2019 & has been associated with this company since 6 years 4 months . was recorded as a recent event.

  • Director Appointment

    Progress on Chetan Kumar Gupta was appointed as a Director was appointed as a Director on 20 Sep 2019 & has been associated with this company since 6 years 4 months . was documented.

  • Company Incorporation

    Progress on Hebert Biotech Private Limited was registered on 20 Sep 2019 with Roc Delhi & aged 6 years 4 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Hebert Biotech Private Limited?

The CIN of Hebert Biotech Private Limited is U52601DL2019PTC355342.

Where is Hebert Biotech Private Limited headquartered?

Hebert Biotech Private Limited is headquartered at C-24, S/F, Dsidc Industrial Complex, Patparganj, New Delhi, Delhi, 110092.

When was Hebert Biotech Private Limited incorporated?

Hebert Biotech Private Limited was incorporated on 20 September 2019.

Who are the current directors of Hebert Biotech Private Limited?

The current directors of Hebert Biotech Private Limited are

What is the primary industry of Hebert Biotech Private Limited?

The primary industry of Hebert Biotech Private Limited is Manufacturing.

Is Hebert Biotech Private Limited a listed company?

Hebert Biotech Private Limited is unlisted.

What is the capital structure of Hebert Biotech Private Limited?

The authorized capital of Hebert Biotech Private Limited is ₹0.50 M, and the paid-up capital is ₹0.20 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available